Strategikon Pharma, Inc. — Form D
Strategikon Pharma, Inc. of San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-21. The offering totals $3.0M, of which $2.3M was reported sold. Industry: Other Technology.
Offering
- Filed: 2025-11-21
- Form: D
- Accession: 0001722200-25-000002
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.3M
- Remaining: $708K
- Investors: 15
- Date of first sale: 2025-05-08
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-564718
Issuer
- Name: Strategikon Pharma, Inc.
- CIK: 0001722200
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 1 Sansome Street, 35th Floor PMB #40621, San Francisco, CA, 94104
- Phone: (609) 529-7806
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Debra Apruzzese | Director | San Francisco, CA |
| Chris Codeanne | Director | San Francisco, CA |
| Anca Copaescu | Director | San Francisco, CA |
| Rob Hess | Director | San Francisco, CA |
| Nathanael Lentz | Director | Spokane, WA |
| Vincent Lepreux | Director | San Francisco, CA |
| Mark Weinstein | Director | San Francisco, CA |
| Paulo Carvalho | Executive Officer | San Francisco, CA |
| Anca Copaescu | Executive Officer | San Francisco, CA |
| Mark Weinstein | Executive Officer | San Francisco, CA |
| Anca Copaescu | Promoter | San Francisco, CA |
| Paulo Carvalho | Director | San Francisco, CA |
| Paulo Carvalho | Promoter | San Francisco, CA |
| Mark Di Ianni | Director | Valley Falls, NY |
| Mark Di Ianni | Executive Officer | Valley Falls, NY |
| Mark Di Ianni | Promoter | Valley Falls, NY |
Other filings by this issuer (2)
More